McKesson strikes $8.3bn deal for Lloydspharmacy owner Celesio

McKesson strikes $8.3bn deal for Lloydspharmacy owner Celesio

Lloydspharmacy owner Celesio has been acquired by US drug wholesaler McKesson for $8.3bn (£5.12bn) including debt.

 

Already have an account?

Want to read more?

Register for LIMITED guest access

Register now

Get premium access

£5 A MONTH for 3 months

Subscribe now